Analysts' Actions: SIRI C ED JACK HES BBT

NEW YORK ( TheStreet) -- CHANGE IN RATINGS

Astea ( ATEA) upgraded to buy at TheStreet Ratings.

Berkshire Hathaway ( BRK.B) upgraded to buy at TheStreet Ratings.

BB&T ( BBT) downgraded at Deutsche from Buy to Hold, Deutsche Bank said. $34 price target. Valuation call, as the stock is up 32% year-to-date.

Ball ( BLL) downgraded at Credit Suisse from Neutral to Underperform, Credit Suisse said. Valuation call, based on a $44 price target.

Berry Petroleum ( BRY) downgraded at Credit Suisse from Neutral to Underperform, Credit Suisse said. $38 price target. Core California project has a muted growth outlook.

Citigroup ( C) upgraded at KBW from Market Perform to Outperform, Keefe, Bruyette & Woods said. $44 price target. Fundamentals should improve and the company trades at two-thirds of its tangible book value.

CBOE ( CBOE) downgraded at Credit Suisse from Neutral to Underperform, Credit Suisse said. $27 price target. Company is facing higher costs and delaying its buyback.

Consolidated Edison ( ED) downgraded at Credit Suisse from Neutral to Underperform, Credit Suisse said. $60 price target. Company trades at a premium valuation and there are risks surrounding the company's upcoming rate case.

Fidelity National ( FIS) downgraded at Credit Suisse from Neutral to Underperform, Credit Suisse said. $35 price target. Industry faces long-term growth headwinds.

Fifth Third ( FITB) downgraded at Wells from Outperform to Market Perform, Wells Fargo said. Valuation call, as the company lacks near-term catalysts.

Healthcare Services ( HCSG) downgraded at Benchmark from Buy to Hold, Benchmark said. Valuation call, based on a $23.50 price target.

Hess ( HES) downgraded at Credit Suisse from Neutral to Underperform, Credit Suisse said. Company faces capital efficiency concerns. $60 price target.

IDEX Corporation ( IEX) downgraded at Oppenheimer to Perform from Outperform, Oppenheimer said. Lower organic growth prospects.

Informatica ( INFA) downgraded at Credit Suisse from Neutral to Underperform, Credit Suisse said. $31 price target. Company will struggle to achieve 2013 earnings expectations.

Jack in the Box ( JACK) downgraded at Credit Suisse from Neutral to Underperform, Credit Suisse said. Stock has made a big run versus its peers. $26 price target.

KB Home ( KBH) downgraded at Citigroup to Sell from Neutral, Citigroup said. $12 price target. Agressive valuation considering leverage.

Knight Transportation ( KNX) downgraded at Credit Suisse from Neutral to Underperform, Credit Suisse said. $15 price target. Stock will likely lag its peers in the coming quarters.

Lennar ( LEN) upgraded at Citigroup to Neutral from Sell, Citigroup said. $35 price target. Underperformed peers despite above average growth.

Liberty Media ( LMCA) upgraded at Citigroup to Buy from Neutral, Citigroup said. $121 price target. Moving toward hard control of Sirius.

Microchip ( MCHP) upgraded at ThinkEquity from Hold to Buy, ThinkEquity said. $38 price target. Recent acquisitions should add to earnings.

ON Semiconductor ( ONNN) upgraded at ThinkEquity from Hold to Buy, ThinkEquity said. New CFO will drive to improve profitability. $8 price target.

Palo Alto ( PANW) rated new Outperform at JMP. $77 price target. Company can capitalize on explosive demand for next-generation security.

PNC Financial ( PNC) upgraded at Deutsche from Hold to Buy, Deutsche Bank said. $71 price target. Stock has lagged its peers for too long. $71 price target.

SAIC ( SAI) downgraded at JP Morgan from Neutral to Underperform, JP Morgan said. $11 price target. Stock trades at a premium to its peers, even though the company still has to restructure.

Sirius XM ( SIRI) rated new Buy at BofA/Merrill. $3.75 price target. Company can leverage its premier content and growing subscriber base.

Silgan ( SLGN) downgraded at Credit Suisse from Neutral to Underperform, Credit Suisse said. $44 price target. Stock should lag its peers in the coming quarters.

Safeway ( SWY) downgraded at Credit Suisse from Neutral to Underperform, Credit Suisse said. $15 price target. Expect the company to lag its peers in the coming quarters.

Integrys Energy ( TEG) upgraded at DA Davidson from Neutral to Buy, DA Davidson said. $59 price target. Asset purchase should boost the rate base.

Tyler Technologies ( TYL) rated new Buy at ThinkEquity. $50 price target. Company is a market leader and can continue to gain market share.

Valmont ( VMI) downgraded at Credit Suisse from Neutral to Underperform, Credit Suisse said. Valuation call, based on a $123 price target.

Wells Fargo ( WFC) downgraded at Deutsche from Buy to Hold, Deutsche Bank said. $36 price target. Valuation call, as the stock is up 25% year-to-date.

WR Berkley ( WRB) downgraded at Goldman to Sell, Goldman Sachs said. Valuation call, based on a $35 price target.

STOCK COMMENTS / EPS CHANGES

ARIAD Pharma ( ARIA) target raised at Jefferies to $28, Jefferies said. Early AP26113 efficacy data encouraging. Buy rating.

Anheuser-Busch InBev ( BUD) added to Key Call List at UBS. US top line momentum with margin upside. $94.06 price target.

Celanese ( CE) numbers cut at UBS. Shares of CE now seen reaching $47, UBS said. Estimates also lowered on new growth guidance.

Generac ( GNRC) estimates, target raised at BMO. Shares of GNRC now seen reaching $30, according to BMO Capital. Estimates also increased, given large power outages. Outperform rating.

International Paper ( IP) numbers reduced at BMO. IP estimates were cut through 2013, BMO Capital said. Company is discounting more and seeing lower demand for pulp.

Kronos Worldwide ( KRO) numbers lowered at Oppenheimer. Shares of KRO now seen reaching $20, Oppenheimer said. Estimates also lowered on ugly pre-announcement. Outperform rating.

Pentair ( PNR) numbers raised at Oppenheimer. Shares of PNR now seen reaching $46, Oppenheimer said. Estimates also raised on merger possibilities. Perform rating.

Travelers ( TRV) cut from Conviction Buy List at Goldman. Valuation call, based on a $75 price target.

STRATEGY CALLS / MARKET CALLS

MedTech sector upgraded at BMO. Medical Technology sector was upgraded from Market Perform to Outperform, BMO Capital said. End-markets are stabilizing and expectations appear reasonable. BAX, MDT, STJ and ZMH are among the analyst's top picks.

>To submit a news tip, email: tips@thestreet.com.

READERS ALSO LIKE:


Follow TheStreet on Twitter and become a fan on Facebook.
This article was written by a staff member of TheStreet.

If you liked this article you might like

SEC's Cyber-Gaffe Highlights Risk of Trump Budget Cuts at Agency

China's Banks Halt Business With North Korea Per United Nations Sanctions

Why Hurricanes Won't Force the Fed to Ditch a December Rate Hike

Fed Pares $4.5 Trillion Balance Sheet But Easy-Money Era Isn't Over

Bank Stocks Move Higher as Fed Decides to Start Unwinding Balance Sheet